IDRSF
Price
$3.59
Change
-$0.01 (-0.28%)
Updated
Jul 23 closing price
Capitalization
742.13M
VYGR
Price
$3.24
Change
-$0.07 (-2.11%)
Updated
Jul 25 closing price
Capitalization
179.29M
5 days until earnings call
Interact to see
Advertisement

IDRSF vs VYGR

Header iconIDRSF vs VYGR Comparison
Open Charts IDRSF vs VYGRBanner chart's image
Idorsia AG
Price$3.59
Change-$0.01 (-0.28%)
Volume$590
Capitalization742.13M
Voyager Therapeutics
Price$3.24
Change-$0.07 (-2.11%)
Volume$581.88K
Capitalization179.29M
IDRSF vs VYGR Comparison Chart in %
Loading...
IDRSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDRSF vs. VYGR commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDRSF is a Hold and VYGR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (IDRSF: $3.59 vs. VYGR: $3.24)
Brand notoriety: IDRSF and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDRSF: 96% vs. VYGR: 81%
Market capitalization -- IDRSF: $742.13M vs. VYGR: $179.29M
IDRSF [@Biotechnology] is valued at $742.13M. VYGR’s [@Biotechnology] market capitalization is $179.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDRSF’s FA Score shows that 0 FA rating(s) are green whileVYGR’s FA Score has 2 green FA rating(s).

  • IDRSF’s FA Score: 0 green, 5 red.
  • VYGR’s FA Score: 2 green, 3 red.
According to our system of comparison, VYGR is a better buy in the long-term than IDRSF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDRSF’s TA Score shows that 3 TA indicator(s) are bullish while VYGR’s TA Score has 4 bullish TA indicator(s).

  • IDRSF’s TA Score: 3 bullish, 3 bearish.
  • VYGR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VYGR is a better buy in the short-term than IDRSF.

Price Growth

IDRSF (@Biotechnology) experienced а +19.67% price change this week, while VYGR (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

VYGR is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDRSF($742M) has a higher market cap than VYGR($179M). VYGR has higher P/E ratio than IDRSF: VYGR (6.00) vs IDRSF (4.54). IDRSF YTD gains are higher at: 322.353 vs. VYGR (-42.857). VYGR has higher annual earnings (EBITDA): -97.25M vs. IDRSF (-189.01M). VYGR has more cash in the bank: 236M vs. IDRSF (64.8M). VYGR has less debt than IDRSF: VYGR (42M) vs IDRSF (1.25B). IDRSF has higher revenues than VYGR: IDRSF (161M) vs VYGR (67M).
IDRSFVYGRIDRSF / VYGR
Capitalization742M179M415%
EBITDA-189.01M-97.25M194%
Gain YTD322.353-42.857-752%
P/E Ratio4.546.0076%
Revenue161M67M240%
Total Cash64.8M236M27%
Total Debt1.25B42M2,986%
FUNDAMENTALS RATINGS
IDRSF vs VYGR: Fundamental Ratings
IDRSF
VYGR
OUTLOOK RATING
1..100
9274
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
32
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10095
PRICE GROWTH RATING
1..100
3464
P/E GROWTH RATING
1..100
979
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VYGR's Valuation (32) in the Biotechnology industry is somewhat better than the same rating for IDRSF (81) in the null industry. This means that VYGR’s stock grew somewhat faster than IDRSF’s over the last 12 months.

VYGR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as IDRSF (100) in the null industry. This means that VYGR’s stock grew similarly to IDRSF’s over the last 12 months.

VYGR's SMR Rating (95) in the Biotechnology industry is in the same range as IDRSF (100) in the null industry. This means that VYGR’s stock grew similarly to IDRSF’s over the last 12 months.

IDRSF's Price Growth Rating (34) in the null industry is in the same range as VYGR (64) in the Biotechnology industry. This means that IDRSF’s stock grew similarly to VYGR’s over the last 12 months.

VYGR's P/E Growth Rating (9) in the Biotechnology industry is significantly better than the same rating for IDRSF (97) in the null industry. This means that VYGR’s stock grew significantly faster than IDRSF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IDRSFVYGR
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
66%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 5 days ago
53%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
51%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 17 days ago
61%
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
Bearish Trend 9 days ago
65%
Bearish Trend 5 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
46%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
IDRSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TTNDY61.230.06
+0.10%
Techtronic Industries Ltd.
QIFTF0.58N/A
N/A
Quorum Information Technologies Inc.
YATRY13.80N/A
N/A
Yamato Holdings Co., Ltd.
CHTH2.90N/A
N/A
CNL Healthcare Pptys Inc.
PWMCF0.01N/A
N/A
Libra Energy Matls Inc.

IDRSF and

Correlation & Price change

A.I.dvisor tells us that IDRSF and KRRO have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IDRSF and KRRO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDRSF
1D Price
Change %
IDRSF100%
N/A
KRRO - IDRSF
29%
Poorly correlated
+0.69%
VYGR - IDRSF
24%
Poorly correlated
-2.11%
ENLV - IDRSF
23%
Poorly correlated
-1.75%
GLABF - IDRSF
23%
Poorly correlated
N/A
IVEVF - IDRSF
21%
Poorly correlated
N/A
More

VYGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with RGNX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
-2.11%
RGNX - VYGR
51%
Loosely correlated
-1.86%
KYMR - VYGR
50%
Loosely correlated
-0.13%
XNCR - VYGR
49%
Loosely correlated
N/A
TRDA - VYGR
49%
Loosely correlated
+2.35%
IMNM - VYGR
47%
Loosely correlated
-3.29%
More